PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The life and death of beta cells

2015-05-19
(Press-News.org) This news release is available in German.

Diabetes is one of the scourges of modern society, and the number of cases is rising every year. Already, there are over 380 million diabetics around the world. The International Diabetes Foundation estimates that by 2030, over half a billion people will be suffering from type 2 diabetes. Today, Switzerland has more than 430,000 diabetics, 40,000 of them with type 1 diabetes.

What both type 1 and type 2 diabetes have in common is a dying off of insulin-producing beta cells, which are found on the pancreas. This deprives the body of an important signalling molecule that plays an essential part in how cells absorb glucose from the blood and metabolise this fuel.

MicroRNA triggers cell death

Until now it was unclear what exactly causes the beta cells to die. Now researchers in the group headed by Markus Stoffel, a professor at ETH Zurich's Institute of Molecular Health Sciences, have discovered new mechanisms governing why these insulin-producing cells cease to function. Their death is triggered by massive overproduction of short strands of ribonucleic acid, known as microRNA (miR) 200.

The researchers discovered that production of miR-200 is greatly increased in the beta cells of diabetic mice, resulting in an excess of this particular microRNA. Using a mouse model, they were able to demonstrate that they could quickly bring about the death of beta cells -- and of the mice -- by forcing miR-200 production.

Conversely, the biologists were also able to use a mouse model to show that by blocking miR-200 they could guarantee the survival of beta cells, even ones under extreme stress. One example of cell stress was when the mice had problematic blood lipid levels; another was when the endoplasmic reticulum, which is where insulin is produced, was under stress.

"These observations are extremely revealing and interesting," says Stoffel. They indicate that miR-200 plays a key role in the survival of this vital cell type. Evidently miR-200 can bring about programmed cell death, known as apoptosis, in beta cells.

Beta cells burn out

Beta cells play a major part in the onset of diabetes. One precursor of diabetes is insulin resistance. In overweight people, for instance, muscle cells react either insufficiently or not at all to insulin, the hormone produced and expressed by beta cells. This causes the beta cells to divide and grow in order to increase insulin production. After a period of working overtime, however, the beta cells are exhausted and die off. The body lacks insulin, and the result is diabetes.

"To a certain extent, the same thing happens in pregnant women, but after the pregnancy this process of cell division and increased insulin release is reversible," says Stoffel. The process is not reversible in obese people, who also have problematic blood lipid levels that put additional stress on their beta cells.

Triad of microRNAs

Stoffel's research group has recently identified several microRNAs that are related to the life and function of beta cells and hence also to diabetes. "It appears that several microRNAs act on beta cells, performing different stress-management tasks," he says.

One of the miR families they have found is central to beta cell division as a response to a need for more insulin. If this strand of RNA is not present, too few cells -- if any -- will divide. A further microRNA family governs how much insulin is produced and expressed. "We've now established that the third family, miR-200, is responsible for the life and death of beta cells," Stoffel summarises.

These short sequences of RNA show great therapeutic potential. Their activity can be inhibited by a corresponding strand that is perfectly complementary to the sequence -- Stoffel calls these antagomirs. Antagomirs are currently undergoing Phase II clinical trials as a treatment for hepatitis C. The antagomir for miR-122 stops the hepatitis C virus from reproducing. Whether and how antagomirs might also be used to deal with the harmful microRNAs implicated in diabetes requires more research.

Essential regulation level

MicroRNAs are part of a complex hierarchical regulatory network involving interactions at several levels. Certain molecules, known as transcription factors, regulate gene activity at the DNA level, for instance by silencing a gene so that it cannot be transcribed. It is at the level of these transcriptions, known as messenger RNA, that microRNAs work - by inhibiting the translation of messenger RNA into a protein. "The fine tuning for which microRNAs are responsible has long been underestimated," says Stoffel. Tiny changes in gene regulation can have huge effects on cell behaviour. These short strands of RNA temper cells' reaction to stress, ensuring it does not get out of hand. "So microRNAs also control crisis situations," says Stoffel.

MicroRNAs have been regulating cell processes for aeons, as evidenced by phylogeny. Humans have around 21,000 genes, of which 700 to 1,000 code for microRNAs -- and 300 of these genes are present in all higher life forms, from worms to humans.

INFORMATION:

Reference

Belgardt B-F, Ahmed K, Spranger M, Latreille M, Denzler R, Kondratiuk N, von Meyenn F, Nunez Villena F, Herrmanns K, Bosco D, Kerr-Conte J, Pattou F, Rülicke T, Stoffel M. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nature Medicine, advanced online publication, Mai 18th 2015. DOI: 10.1038/nm.3862



ELSE PRESS RELEASES FROM THIS DATE:

New risk factor for pregnancies

New risk factor for pregnancies
2015-05-19
This news release is available in French. Women who were born preterm have a higher risk of giving birth to preterm children, according to a study, published in the journal Obstetrics & Gynecology, from researchers of the CHU Sainte-Justine and the University of Montreal. The researchers demonstrated that 13% of women born before 37 weeks of gestation gave birth prematurely at least once, compared to 9.5% of women born at term. Interestingly, this figure increased to 14% in women born before 32 weeks. "The difference is not alarming considering that according to ...

DATECAN initiative publishes guidelines for time-to-event end point definitions in breast cancer trials

2015-05-19
The DATECAN initiative, Definition for the Assessment of Time-to-event Endpoints in CANcer trials, has published Guidelines for time-to-event end point definitions in breast cancer trials in a recent issue of the Annals of Oncology. Standardized definitions can help researchers to more easily compare the results of clinical trials. The guidelines developed by the DATECAN initiative can help researchers to have a more uniform usage of key endpoints in the design, conduct, and reporting of clinical trials for patients with breast cancer. DATECAN was initiated by statisticians ...

Study reveals intestinal bacteria succession during recovery from cholera in Bangladesh

2015-05-19
A new study delineates a sequential pattern of changes in the intestinal microbial population of patients recovering from cholera in Bangladesh, findings that may point to ways of speeding recovery from the dangerous diarrheal disease. The report also finds what appear to be consistent differences between the gut microbial population - also called the microbiota - of individuals in developed countries like the U.S. and those the developing world and provides some of the most complete evidence that the gut microbiota usually return to normal after cholera infection. Their ...

Microclinics help keep Kenyan HIV patients in care

2015-05-19
A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics -- an innovative intervention that mobilized rural Kenyan HIV patients' informal social networks to support their staying in care. The results showed that microclinics cut in half the normal rate of disengagement from care, which was defined as missing a clinic appointment by 90 days or more, when compared to the control group, and reduced the perceived stigma of HIV by 25 percent within ...

Baby teethers are a novel source of infant exposure to endocrine disruptors

2015-05-19
A new study has found that endocrine disrupting chemicals--which can interfere with the actions of hormones in the body--are present in some plastic teethers for babies, and the chemicals can leach out of the products. Investigators detected significant endocrine activity in 2 of 10 plastic teethers. One teether contained methyl-, ethyl- and propylparaben, while the second contained at least 6 different endocrine disrupting compounds that remain so far unidentified. "The good news is that most of teethers we investigated did not contain endocrine disruptors. However, ...

Australian researcher helps with Ebola vaccine trials

2015-05-19
An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines. Associate Professor Manoj Gambhir, from Monash University's Department of Epidemiology and Preventive Medicine, is part of the team working on the research. Led by University of Texas Austin researcher Dr Steve Bellan, and in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the study on the design of CDC's vaccine trial in Sierra Leone is published in The Lancet Infectious Diseases. Safe and effective vaccines could help ...

The road to successful uterus transplantation to restore fertility

2015-05-19
Swedish clinicians recently reported the first live birth after uterus transplantation, which was followed by two more uneventful births and another pregnancy that is near term. In a new Acta Obstetricia et Gynecologica Scandinavica commentary, one of the leaders behind these successes, Professor Mats Brannström, provides insights into how the Swedish uterus transplant project was initiated and its long research journey that spans over more than a decade. The first clinical uterus transplantation trial, which enrolled nine women, was initiated in early 2013 and ...

Task force offers recommendations on epilepsy treatments in women and girls

2015-05-19
The anti-epilepsy drug valproate should be avoided whenever possible in women who may become pregnant due to a high risk of malformations and developmental problems in babies who are exposed to the drug before birth. The guidance comes from a joint task force of the Commission of European Affairs of the International League Against Epilepsy and the European Academy of Neurology. In an Epilepsia paper, the task force notes that it is also important that those women who need valproate to control their seizures are not denied the most effective treatment, as uncontrolled ...

Physical training helps women with polycystic ovary syndrome

2015-05-19
Women with polycystic ovary syndrome, a hormonal disorder that affects 5% to 10% of the female population of fertile age, often experience sexual dysfunction and low self-esteem, but a new study shows that physical resistance training can help. Women who participated in physical resistance training--which included upper body, lower body, and abdominal exercises--experienced considerable improvements related to sexual function, desire, arousal, lubrication, and pain, as well as decreases in anxiety and depression. The authors noted that the Journal of Sexual Medicine ...

The extent of toxin accumulation in birds off the coast of Canada

2015-05-19
Toxins known as perfluoroalkyl substances have become virtually ubiquitous throughout the environment, and various national and international voluntary phase-outs and restrictions on these compounds have been implemented over the last 10 to 15 years. Investigators who examined trends in the accumulation of these toxins in the eggs of four species of aquatic birds from the Pacific coast of Canada from the early 1990s to 2011 report that the concentrations of some of these compounds are decreasing in line with manufacturing phase-outs, while others continue to increase ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

[Press-News.org] The life and death of beta cells